Study of a Tankyrase Inhibitor RK-582 for Patients With Unresectable Metastatic Colorectal Cancer

Clinical trial NCT06853496 · RECRUITING

Trial details

NCT number: NCT06853496
Sponsor: Eiji Shinozaki
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Unresectable Colorectal Neoplasm Metastasis

Start date: 2025-03-13
Primary completion: 2027-03-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.